A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia
Clinical trial NCT04638543 · COMPLETED
Trial details
- NCT number
- NCT04638543
- Sponsor
- Atom Therapeutics Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-27
- Primary completion
- 2021-10-26
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.